Guggenheim Maintains Buy on Tenet Healthcare, Lowers Price Target to $242

Benzinga · 2d ago
Guggenheim analyst Jason Cassorla maintains Tenet Healthcare (NYSE:THC) with a Buy and lowers the price target from $252 to $242.